Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.
D000172:Acromegaly / Q000097:blood* / Q000175:diagnosis* / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D018491:Dopamine Agonists / Q000627:therapeutic use; D019382:Human Growth Hormone / Q000097:blood*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008565:Membrane Proteins / Q000037:antagonists & inhibitors; D011159:Population Surveillance; D016634:Radiosurgery; D013004:Somatostatin / Q000031:analogs & derivatives; D013997:Time Factors; D016896:Treatment Outcome
D018491:Dopamine Agonists; D008565:Membrane Proteins; C405010:delta-hGHR; D019382:Human Growth Hormone; D013004:Somatostatin; D007334:Insulin-Like Growth Factor I